Adient Clocks 10% Revenue Decline In Q1
Adient PLC (NYSE:ADNT) reported a first-quarter FY22 sales decline of 10% year-on-year, to $3.48 billion, beating the analyst consensus of $3.11…
12 Consumer Discretionary Stocks Moving In Friday’s After-Market Session
Gainers
GameStop (NYSE:GME) stock rose 15.7% to $151.6 during Friday's after-market session. Trading volume for this security closed at 471.4K, accounting for 20.1% of its average full-day volume over the last 100 days. The company's market cap stands at $11.5 billion.
Barclays Downgrades Adient to Equal-Weight, Lowers Price Target to $43
Barclays analyst Brian Johnson downgrades Adient (NYSE:ADNT) from Overweight to Equal-Weight and lowers the price target from $50 to $43.
Adient Q4 EPS $(0.24) Beats $(0.59) Estimate, Sales $2.77B Down From $3.60B YoY
Adient (NYSE:ADNT) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.59) by 59.32 percent. This is a 120.87 percent decrease over earnings of $1.15 per share from the same
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Analyst Ratings For Adient
Analysts have provided the following ratings for Adient (NYSE:ADNT) within the last quarter:
Barclays Maintains Overweight on Adient, Lowers Price Target to $53
Barclays analyst Brian Johnson maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $54 to $53.
Wells Fargo Maintains Overweight on Adient, Lowers Price Target to $48
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $50 to $48.
Morgan Stanley Maintains Underweight on Adient, Lowers Price Target to $38
Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and lowers the price target from $40 to $38.